Fidelity Investments’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $22.8M | Buy |
+1,414,190
| New | +$22.8M | ﹤0.01% | 1656 |
|
2024
Q2 | – | Sell |
-1
| Closed | -$201 | – | 5475 |
|
2024
Q1 | $201 | Buy |
+1
| New | +$201 | ﹤0.01% | 4914 |
|
2022
Q1 | – | Sell |
-10
| Closed | -$1K | – | 5177 |
|
2021
Q4 | $1K | Buy |
10
+3
| +43% | +$300 | ﹤0.01% | 4137 |
|
2021
Q3 | $2K | Hold |
7
| – | – | ﹤0.01% | 4012 |
|
2021
Q2 | $2K | Hold |
7
| – | – | ﹤0.01% | 3922 |
|
2021
Q1 | $2K | Hold |
7
| – | – | ﹤0.01% | 3718 |
|
2020
Q4 | $3K | Buy |
+7
| New | +$3K | ﹤0.01% | 3520 |
|
2020
Q3 | – | Sell |
-6
| Closed | -$2K | – | 3802 |
|
2020
Q2 | $2K | Buy |
+6
| New | +$2K | ﹤0.01% | 3364 |
|
2020
Q1 | – | Sell |
-2
| Closed | -$1K | – | 3866 |
|
2019
Q4 | $1K | Sell |
2
-323
| -99% | -$162K | ﹤0.01% | 3646 |
|
2019
Q3 | $140K | Sell |
325
-41,740
| -99% | -$18M | ﹤0.01% | 2689 |
|
2019
Q2 | $50.1M | Buy |
42,065
+3,098
| +8% | +$3.69M | 0.01% | 1217 |
|
2019
Q1 | $48.6M | Buy |
38,967
+3,651
| +10% | +$4.55M | 0.01% | 1231 |
|
2018
Q4 | $33.4M | Sell |
35,316
-2,699
| -7% | -$2.56M | ﹤0.01% | 1336 |
|
2018
Q3 | $54.7M | Buy |
38,015
+409
| +1% | +$589K | 0.01% | 1231 |
|
2018
Q2 | $60.7M | Buy |
37,606
+2,900
| +8% | +$4.68M | 0.01% | 1186 |
|
2018
Q1 | $56.3M | Buy |
34,706
+6,319
| +22% | +$10.3M | 0.01% | 1240 |
|
2017
Q4 | $47.7M | Buy |
28,387
+13,584
| +92% | +$22.8M | 0.01% | 1322 |
|
2017
Q3 | $20.7M | Sell |
14,803
-233
| -2% | -$326K | ﹤0.01% | 1683 |
|
2017
Q2 | $16.8M | Buy |
+15,036
| New | +$16.8M | ﹤0.01% | 1751 |
|
2016
Q1 | – | Sell |
-1,492
| Closed | -$853K | – | 2692 |
|
2015
Q4 | $853K | Buy |
1,492
+99
| +7% | +$56.6K | ﹤0.01% | 2541 |
|
2015
Q3 | $780K | Buy |
1,393
+1,268
| +1,014% | +$710K | ﹤0.01% | 2550 |
|
2015
Q2 | $100K | Buy |
+125
| New | +$100K | ﹤0.01% | 2708 |
|